Czechia· CZ-0236754
CEFTRIAXON APTAPHARMA
A ceftriaxone product containing ceftriaxone disodium trihemihydrate, registered in Czechia by Apta Medica Internacional d.o.o., Ljubljana. The same ATC class is registered in 19 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Ceftriaxone is registered in 19 of 19 countries.
Countries holding a registration under ATC J01DD04 (ceftriaxone), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 11 of them publish a price we can compare per daily dose
Ceftriaxone · ATC J01DD04
19 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of ceftriaxone costs, country by country.
Normalised to the WHO defined daily dose (2 g), the median price runs from $3.23 in Finland to $33.98 in Switzerland — a ×11 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Ceftriaxone · price per daily dose (2 g)
USD · FX 28 Sept 2026
- CH Switzerland$33.98
- FR France$13.68
- ES Spain$5.69
- FI Finland$3.23
The record
At a glance
SÚKL (Czech Republic)- Active substance
- CEFTRIAXONE DISODIUM TRIHEMIHYDRATE
- Manufacturer
- Apta Medica Internacional d.o.o., Ljubljana
- Country
- Czechia (CZ)
- ATC code
- J01DD04
- ATC class
- Ceftriaxone
- Defined daily dose
- 2 g, P
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- September 28, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
233 interactions on record for ceftriaxone.
Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ceftriaxone · interactions on record
233 records
- 7 severe
- 20 moderate
- 3 minor
- 203 info
Most severe, free to view
- Calcium gluconateA12AA03severe
- Calcium chlorideA12AA07severe
- Calcium glucoheptonateA12AA10severe
- Calcium chlorideB05XA07severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Ceftriaxone in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandCefonovaDr. Friedrich Eberth Arzneimittel GmbH
- BelgiumCeftriaxon Hameln 2 gHameln Pharma
- SpainCEFTRIAXONA FRESENIUS KABI 2 g POLVO PARA SOLUCIÓN PARA PERFUSIÓN EFGFresenius Kabi España, S.A.U.
- PolandBiotraksonZakłady Farmaceutyczne POLPHARMA S.A.
- NorwayCeftriaxon Fresenius Kabi2care4 ApS
- SwedenCeftriaxon Fresenius Kabi 2 g Pulver till infusionsvätska, lösningFresenius Kabi AB
- IcelandCeftriaxon Fresenius KabiFresenius Kabi AB
- SwitzerlandRocephin 2 g i.v., Pulver zur Herstellung einer InfusionslösungRoche Pharma (Schweiz) AG
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Ceftriaxon Aptapharma, Ceftriaxon Ashcure
- Belgium · Ceftriaxon Hameln, Ceftriaxone Fresenius Kabi
- Bulgaria · Медаксон, Цефамед
- Cyprus · Ceftriaxone Sapiens, Ceftrix
- Germany · Ceftriaxon Cnp, Ceftriaxon Dali Pharma
- Denmark · Ceftriaxon Fresenius Kabi, Ceftriaxon Hameln
- Estonia · ceftriaxone Kabi, Ceftriaxone Mip
- Spain · Ceftriaxona Fresenius Kabi, Ceftriaxona Ldp Torlan
- Finland · Ceftriaxon Fresenius Kabi, Ceftriaxon Hameln
- France · Ceftriaxone Almus, Ceftriaxone Arrow
- United Kingdom (Northern Ireland) · Ceftriaxone, Ceftriaxone Aft Pharma Uk
- Greece · Bresec, Bresec(Iv)
- Croatia · Ceftriakson Aptapharma, Ceftriakson Pontus
- Hungary · Ceftriaxon Aptapharma, Ceftriaxon Kabi
- Ireland · Ceftriaxone Hameln, Ceftriaxone Jed Pharma
- Iceland · Ceftriaxon Fresenius Kabi, Ceftriaxon Navamedic
- Italy · Bixon, Caritex
- Lithuania · Ceftriaxone Ashcure, Ceftriaxone Kabi
- Luxembourg · Ceftriaxone Fresenius Kabi, Rocephine
- Latvia · Ceftriaxon Mip, Ceftriaxone Ashcure
- Malta · Ceftriaxone Ashcure, Ceftriaxone Dali Pharma
- Netherlands · Ceftriaxon Fresenius Kabi, Ceftriaxon Hameln
- Norway · Ceftriaxon Fresenius Kabi, Ceftriaxon Hameln
- Poland · Biotrakson, Ceftriaxon Aptapharma
- Portugal · Betasporina, Betasporina Im
- Romania · Cefort, Ceftriaxonă Aptapharma
- Sweden · Ceftriaxon Fresenius Kabi, Ceftriaxon Hameln
- Slovenia · Ceftriakson Aptapharma, Ceftriakson Pontus
- Slovakia · Ceftriaxón Aptapharma, Ceftriaxon Kabi
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/258ce4ff-3e84-4177-b4f0-0c598efb3858 GET /v1/drugs/258ce4ff-3e84-4177-b4f0-0c598efb3858?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "INJ/INF PLV SOL",
"source": "sukl",
"strength": "2G",
"pack_size": "5",
"substance": "CEFTRIAXONE DISODIUM TRIHEMIHYDRATE",
"cz_kod_sukl": "0236754",
"product_type": "CH",
"substance_codes": "11418",
"registration_state": "R",
"registration_number": "15/419/18-C"
}See everything about ceftriaxone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.